On the basis of the foregoing, we conclude that any decision as to the design of the regulatory environment should follow a process that takes account of the values, hope and concerns of all stakeholders involved. In particular we stress the need for careful planning of consent obligations cobining traditional legal methods with and adequate institutional setup. In order to enhance the translational exploitation of biobanks, we further emphasize the pressing need to carefully consider a great variety of strategies and policy choices relating to IPR.
Personalized Medicine. 2014;11(5):497-508. © 2014 Future Medicine Ltd.